CJC-1295 + Ipamorelin: GH Optimization Stack The GHRH + GHRP combination amplifies growth hormone release beyond what either peptide achieves individually
When fat is lost too quickly, the skin may not have enough time to shrink back, causing a sagging or deflated appearance
Take control of your health and request a consultation today
Even on reduced appetite, making every calorie count by choosing mineral-dense foods is the most effective long-term strategy
doi:10.1056/NEJMoa2416394 Harbi M, Ashour A, Alorfi N, et al
Retatrutide (2026) Semaglutide Mechanism: GLP-1 receptor agonist FDA Status: Approved for diabetes and weight management Expected Weight Loss: 1520% body weight Administration: Weekly injection Onset: Appetite changes within first few weeks Cost: Membership pricing at Better Med Spa see plans Tirzepatide Mechanism: Dual GIP + GLP-1 receptor agonist FDA Status: Approved for diabetes and weight management Expected Weight Loss: Up to 22% body weight Administration: Weekly injection Onset: Often faster appetite suppression Cost: Membership pricing at Better Med Spa see plans Retatrutide Mechanism: Triple agonist (GLP-1 + GIP + Glucagon) FDA Status: NOT approved investigational only Expected Weight Loss: Early data suggests very potent effects (up to 24% in trials) Administration: Weekly injection (investigational protocols) Onset: Under investigation Cost: Not yet available What Are Semaglutide, Tirzepatide, and Retatrutide
